Correction: Identification of druggable genetic targets for prostate cancer risk based on mendelian randomization and single‑cell RNA sequencing.

IF 1.8 4区医学 Q3 UROLOGY & NEPHROLOGY

International Urology and Nephrology Pub Date : 2025-05-19 DOI:10.1007/s11255-025-04573-4

Liantai Song, Xinyang He, Yibing Duan, Yifan Chi, Reng Li, Cancan Li, Yutian Liu, Mengxin Yang, Jiameng Wei, Yujia Zhao, Qian Xu

引用次数: 0

查看原文本刊更多论文

更正：基于孟德尔随机化和单细胞RNA测序的前列腺癌风险的可药物基因靶点鉴定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Urology and Nephrology 医学-泌尿学与肾脏学

CiteScore

3.40

自引率

5.00%

发文量

329

审稿时长

1.7 months

期刊介绍： International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.